TIAA CREF Investment Management’s Editas Medicine EDIT Stock Holding History

TIAA CREF Investment Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.97M	Sell	80,445 -73,464	-48%	-$1.66M	﹤0.01%	2005
2018 Q4	$3.5M	Sell	153,909 -3,672	-2%	-$99.9K	﹤0.01%	1600
2018 Q3	$5.01M	Sell	157,581 -7,950	-5%	-$257K	﹤0.01%	1568
2018 Q2	$5.93M	Sell	165,531 -208,270	-56%	-$7.37M	﹤0.01%	1487
2018 Q1	$12.4M	Buy	373,801 +5,478	+1%	+$195K	0.01%	989
2017 Q4	$11.3M	Buy	368,323 +92,606	+34%	+$2.33M	0.01%	1064
2017 Q3	$6.62M	Buy	275,717 +125,969	+84%	+$2.4M	﹤0.01%	1446
2017 Q2	$2.51M	Buy	149,748 +131,389	+716%	+$2.37M	﹤0.01%	2049
2017 Q1	$410K	Sell	18,359 -2,319	-11%	-$48.1K	﹤0.01%	2854
2016 Q4	$336K	Sell	20,678 -450	-2%	-$6.83K	﹤0.01%	2953
2016 Q3	$285	Buy	21,128 +867	+4%	+$17.8K	﹤0.01%	3006
2016 Q2	$494K	Buy	20,261 +5,254	+35%	+$177K	﹤0.01%	2861
2016 Q1	$518K	Buy	+15,007	New	+$394K	﹤0.01%	2772

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

OTPPB

Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

TIAA CREF Investment Management's EDIT Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Editas Medicine (EDIT) stake by 48% in Q1 2019, selling an estimated $1.66M and leaving 80,445 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #2005.

TIAA CREF Investment Management first reported a position in EDIT in Q1 2016 and has held it in 13 quarters since. The position peaked at $12.4M in Q1 2018. 201 funds tracked by Wall St. Rank hold EDIT as of Q1 2019.

TIAA CREF Investment Management held 80,445 shares of Editas Medicine worth $1.97M as of Q1 2019.
TIAA CREF Investment Management sold 73,464 Editas Medicine shares in Q1 2019, an estimated $1.66M.
Editas Medicine made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2005 holding.
TIAA CREF Investment Management first reported a position in Editas Medicine in Q1 2016 and has held it in 13 quarters since.
TIAA CREF Investment Management's Editas Medicine position peaked at $12.4M in Q1 2018.
201 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.